Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Your Article Summary
A Trade Agreement's Impact On Access To Generic Drugs
Health Affairs, 09/23/09
Shaffer ER et al. – Millions of people lack access to affordable medicines. The intellectual property rules in the Central America Free Trade Agreement (CAFTA) provide pharmaceutical companies with monopoly protections that allow them to market some drugs without competition by less costly generics.
Related Articles
Teva Receives Final Approval For Generic Prevacid Delayed-Release Capsules
Teva Pharmaceutical Industries, 11/11/09
Relevance Score: 68%
Cephalon Notified of Generic Filing for Armodafinil Tablets
Cephalon, 10/22/09
Relevance Score: 68%
Mylan Receives FDA Approval for Generic Version of Prevacid Through its Subsidiary Matrix Laboratories
Mylan, 11/11/09
Relevance Score: 67%
Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots
Diagnostic Microbiology and Infectious Disease, 10/22/09
Relevance Score: 67%
Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment SinemetÂ
Mylan, 10/01/09
Relevance Score: 67%
Today in Law/Ethics/Regulations...keeping you current
Receive free subspecialty "5-minute updates" via email
I.T. Loan Guarantee Provision Hits House Floor
HealthDataManagement, 12/09/09
Testing the Health Records Bank Model
HealthDataManagement, 12/09/09
The effect of education on health among US residents in relation to country of birth
Health Economics, 12/08/09
Article Search
Sponsor


See Latest Articles


